Insider Transactions in Q4 2021 at Castle Biosciences Inc (CSTL)
Insider Transaction List (Q4 2021)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 10
2021
|
Tobin W Juvenal Chief Commercial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
427
-8.08%
|
$17,080
$40.52 P/Share
|
|
Dec 10
2021
|
Tobin W Juvenal Chief Commercial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
1,750
+24.89%
|
-
|
|
Dec 10
2021
|
Derek J Maetzold Pres. & Chief Exec. Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
2,111
-0.91%
|
$84,440
$40.52 P/Share
|
|
Dec 10
2021
|
Derek J Maetzold Pres. & Chief Exec. Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
5,363
+2.26%
|
-
|
|
Dec 10
2021
|
Kristen M Oelschlager Chief Operating Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
516
-0.52%
|
$20,640
$40.52 P/Share
|
|
Dec 10
2021
|
Kristen M Oelschlager Chief Operating Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
1,750
+1.73%
|
-
|
|
Dec 10
2021
|
Bernhard E. Spiess Chief Business Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
366
-2.43%
|
$14,640
$40.52 P/Share
|
|
Dec 10
2021
|
Bernhard E. Spiess Chief Business Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
1,500
+9.06%
|
-
|
|
Dec 10
2021
|
Frank Stokes Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
895
-10.88%
|
$35,800
$40.52 P/Share
|
|
Dec 10
2021
|
Frank Stokes Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
2,000
+19.56%
|
-
|
|
Nov 16
2021
|
Derek J Maetzold Pres. & Chief Exec. Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
15,409
+4.86%
|
$46,227
$3.72 P/Share
|
|
Nov 15
2021
|
Derek J Maetzold Pres. & Chief Exec. Officer |
SELL
Open market or private sale
|
Direct |
16,406
-2.72%
|
$853,112
$52.76 P/Share
|
|
Nov 15
2021
|
Derek J Maetzold Pres. & Chief Exec. Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
16,406
+5.15%
|
$32,812
$2.36 P/Share
|
|
Nov 10
2021
|
Derek J Maetzold Pres. & Chief Exec. Officer |
SELL
Open market or private sale
|
Indirect |
1,200
-0.1%
|
$67,200
$56.46 P/Share
|
|
Nov 09
2021
|
Derek J Maetzold Pres. & Chief Exec. Officer |
SELL
Open market or private sale
|
Indirect |
2,500
-0.15%
|
$142,500
$57.17 P/Share
|
|
Nov 08
2021
|
Daniel Bradbury Director |
SELL
Open market or private sale
|
Indirect |
5,554
-0.79%
|
$338,794
$61.3 P/Share
|
|
Nov 04
2021
|
Daniel Bradbury Director |
SELL
Open market or private sale
|
Indirect |
4,446
-0.83%
|
$271,206
$61.18 P/Share
|
|
Oct 22
2021
|
Daniel Bradbury Director |
SELL
Open market or private sale
|
Indirect |
5,000
-0.93%
|
$310,000
$62.71 P/Share
|
|
Oct 21
2021
|
Daniel Bradbury Director |
SELL
Open market or private sale
|
Indirect |
5,000
-0.69%
|
$310,000
$62.98 P/Share
|
|
Oct 21
2021
|
Derek J Maetzold Pres. & Chief Exec. Officer |
SELL
Open market or private sale
|
Indirect |
2,500
-0.2%
|
$157,500
$63.44 P/Share
|
|
Oct 20
2021
|
Derek J Maetzold Pres. & Chief Exec. Officer |
SELL
Open market or private sale
|
Indirect |
2,500
-0.3%
|
$162,500
$65.55 P/Share
|
|
Oct 19
2021
|
Derek J Maetzold Pres. & Chief Exec. Officer |
SELL
Open market or private sale
|
Indirect |
2,500
-0.2%
|
$167,500
$67.0 P/Share
|
|
Oct 06
2021
|
Derek J Maetzold Pres. & Chief Exec. Officer |
SELL
Open market or private sale
|
Indirect |
2,500
-0.29%
|
$157,500
$63.82 P/Share
|
|
Oct 05
2021
|
Derek J Maetzold Pres. & Chief Exec. Officer |
SELL
Open market or private sale
|
Indirect |
2,500
-0.29%
|
$155,000
$62.43 P/Share
|
|
Oct 05
2021
|
Daniel Bradbury Director |
SELL
Open market or private sale
|
Indirect |
5,000
-0.68%
|
$310,000
$62.59 P/Share
|
|
Oct 04
2021
|
Derek J Maetzold Pres. & Chief Exec. Officer |
SELL
Open market or private sale
|
Indirect |
2,500
-0.14%
|
$152,500
$61.6 P/Share
|
|
Oct 04
2021
|
Daniel Bradbury Director |
SELL
Open market or private sale
|
Indirect |
5,000
-0.54%
|
$305,000
$61.8 P/Share
|